Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes.

ABSTRACT:

Background

Since national essential medicine lists guide the procurement of medicines for populations in many countries, and cardiovascular diseases are the leading cause of death globally, including cardiovascular medicines on these lists can significantly impact healthcare outcomes.

Methods

In this cross-sectional study, national essential medicines' lists from 158 countries were analysed on whether or not they included medicines to treat ischemic heart disease, cerebrovascular disease, and hypertensive heart disease. A linear regression model was used to evaluate the association between countries' coverage scores and amenable mortality.

Results

Listing of cardiovascular disease treatment was associated with amenable mortality from hypertensive heart disease. Health

SUBMITTER: Heredia C 

PROVIDER: S-EPMC11771043 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature